ABCC4 and hyperlipidemia: It might be a boon to patients who continue taking drugs with MRP4-inhibitory activity; however, further studies should be performed to find a resolution of this issue because they have systemic diseases, such as hyperlipidemia, hypertension and cancer, that may impose another stress in addition to aging [13,23,24].